Could your own stem cells halt MS? early trial investigates nerve repair
NCT ID NCT04749667
Summary
This study is testing whether injecting a patient's own bone marrow stem cells into the spinal fluid can help repair nerve damage and slow the progression of multiple sclerosis (MS). It involves 18 adults with progressive MS, who will receive either the stem cell treatment or a placebo injection in a carefully controlled, blinded study. The main goal is to see if the treatment improves nerve signaling and is safe, while also checking for changes in disability, brain scans, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akershus university hospital
Lørenskog, Akershus, Norway
-
Haukeland University Hospital
Bergen, Vestland, Norway
-
St.Olav university hospital
Trondheim, Trøndelag, Norway
-
University hospital of North Norway
Tromsø, Troms Og Finnmark, Norway
Conditions
Explore the condition pages connected to this study.